Does EVEROLIMUS Cause Transplant rejection? 248 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 248 reports of Transplant rejection have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 0.6% of all adverse event reports for EVEROLIMUS.
248
Reports of Transplant rejection with EVEROLIMUS
0.6%
of all EVEROLIMUS reports
15
Deaths
103
Hospitalizations
How Dangerous Is Transplant rejection From EVEROLIMUS?
Of the 248 reports, 15 (6.0%) resulted in death, 103 (41.5%) required hospitalization, and 15 (6.0%) were considered life-threatening.
Is Transplant rejection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVEROLIMUS. However, 248 reports have been filed with the FAERS database.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Transplant rejection?
TACROLIMUS (3,526)
MYCOPHENOLATE MOFETIL (2,500)
PREDNISONE (1,111)
CYCLOSPORINE (903)
PREDNISOLONE (860)
METHYLPREDNISOLONE (779)
SIROLIMUS (698)
BASILIXIMAB (554)
MYCOPHENOLIC ACID (445)
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (437)
Which EVEROLIMUS Alternatives Have Lower Transplant rejection Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE